Ranbaxy Laboratories reports Q4 net profit of Rs.139.07 Crores

Ranbaxy Laboratories Ltd has announced the following Unaudited results for the quarter & year ended December 31, 2006:

The Company has posted a profit after tax of Rs 1390.70 million for the quarter ended December 31, 2006 as compared to Rs 979.90 million for the quarter ended December 31, 2005. Total Income (net of excise) has increased from Rs 9108.40 million for the quarter ended December 31, 2005 to Rs 10353.30 million for the quarter ended December 31, 2006.

The Company has posted a profit after tax of Rs 3864.50 million for the year ended December 31, 2006 as compared to Rs 2237.00 million for the year ended December 31, 2005. Total Income (net of excise) has increased from Rs 36513.00 million for the year ended December 31, 2005 to Rs 40049.80 million for the year ended December 31, 2006.

The Consolidated results (as per Indian GAAP) are as follows:

The Group has posted a profit after tax & minority Interests of Rs 1833.00 million for the quarter ended December 31, 2006 as compared to Rs 686.00 million for the quarter ended December 31, 2005. Total Income (net of excise) has increased from Rs 14503.00 million for the quarter ended December 31, 2005 to Rs 17793.00 million for the quarter ended December 31, 2006.

The Group has posted a profit after tax & minority Interests of Rs 5151.00 million for the year ended December 31, 2006 as compared to Rs 2617.00 million for the year ended December 31, 2005. Total Income (net of excise) has increased from Rs 53747.00 million for the year ended December 31, 2005 to Rs 61637.00 million for the year ended December 31, 2006.

The figures for the year ended December 31, 2005 are Audited.

Source : Equity Bulls

Keywords